APA (7th ed.) Citation

CP, R., & J, S. (2023). Case series: Voluntary discontinuation of sublingual buprenorphine treatment for opioid use disorder using extended-release buprenorphine. The American journal on addictions, 32(3), 314. https://doi.org/10.1111/ajad.13414

Chicago Style (17th ed.) Citation

CP, Rodriguez, and Suzuki J. "Case Series: Voluntary Discontinuation of Sublingual Buprenorphine Treatment for Opioid Use Disorder Using Extended-release Buprenorphine." The American Journal on Addictions 32, no. 3 (2023): 314. https://doi.org/10.1111/ajad.13414.

MLA (9th ed.) Citation

CP, Rodriguez, and Suzuki J. "Case Series: Voluntary Discontinuation of Sublingual Buprenorphine Treatment for Opioid Use Disorder Using Extended-release Buprenorphine." The American Journal on Addictions, vol. 32, no. 3, 2023, p. 314, https://doi.org/10.1111/ajad.13414.